nodes	percent_of_prediction	percent_of_DWPC	metapath
Imipramine—DRD2—nicotine dependence	0.617	1	CbGaD
Imipramine—ORM1—saliva—nicotine dependence	0.00924	0.138	CbGeAlD
Imipramine—Withdrawal symptom—Varenicline—nicotine dependence	0.00713	0.0445	CcSEcCtD
Imipramine—Drug withdrawal syndrome—Varenicline—nicotine dependence	0.00596	0.0372	CcSEcCtD
Imipramine—Extrapyramidal symptoms—Varenicline—nicotine dependence	0.00564	0.0352	CcSEcCtD
Imipramine—Sleep disturbance—Varenicline—nicotine dependence	0.00522	0.0325	CcSEcCtD
Imipramine—Delusion—Varenicline—nicotine dependence	0.00413	0.0258	CcSEcCtD
Imipramine—Mania—Varenicline—nicotine dependence	0.00402	0.0251	CcSEcCtD
Imipramine—KCND2—cardiovascular system—nicotine dependence	0.0039	0.058	CbGeAlD
Imipramine—Extrapyramidal disorder—Varenicline—nicotine dependence	0.00388	0.0242	CcSEcCtD
Imipramine—Mydriasis—Varenicline—nicotine dependence	0.00367	0.0229	CcSEcCtD
Imipramine—Endocrine disorder—Varenicline—nicotine dependence	0.00353	0.022	CcSEcCtD
Imipramine—KCND3—cardiovascular system—nicotine dependence	0.0034	0.0506	CbGeAlD
Imipramine—Aggression—Varenicline—nicotine dependence	0.00333	0.0208	CcSEcCtD
Imipramine—KCND2—midbrain—nicotine dependence	0.00305	0.0453	CbGeAlD
Imipramine—Coordination abnormal—Varenicline—nicotine dependence	0.00298	0.0186	CcSEcCtD
Imipramine—Blood pressure increased—Varenicline—nicotine dependence	0.00292	0.0182	CcSEcCtD
Imipramine—Nightmare—Varenicline—nicotine dependence	0.00282	0.0176	CcSEcCtD
Imipramine—KCND3—midbrain—nicotine dependence	0.00266	0.0395	CbGeAlD
Imipramine—Sleep disorder—Varenicline—nicotine dependence	0.00245	0.0153	CcSEcCtD
Imipramine—Disorientation—Varenicline—nicotine dependence	0.00237	0.0148	CcSEcCtD
Imipramine—Libido decreased—Varenicline—nicotine dependence	0.00229	0.0143	CcSEcCtD
Imipramine—Hot flush—Varenicline—nicotine dependence	0.00227	0.0142	CcSEcCtD
Imipramine—Menopausal symptoms—Varenicline—nicotine dependence	0.00225	0.014	CcSEcCtD
Imipramine—Cerebrovascular accident—Varenicline—nicotine dependence	0.00217	0.0135	CcSEcCtD
Imipramine—Disturbance in sexual arousal—Varenicline—nicotine dependence	0.00211	0.0131	CcSEcCtD
Imipramine—Affect lability—Varenicline—nicotine dependence	0.00209	0.013	CcSEcCtD
Imipramine—Psychotic disorder—Varenicline—nicotine dependence	0.00207	0.0129	CcSEcCtD
Imipramine—Urinary retention—Varenicline—nicotine dependence	0.00202	0.0126	CcSEcCtD
Imipramine—Mood swings—Varenicline—nicotine dependence	0.00201	0.0125	CcSEcCtD
Imipramine—Liver function test abnormal—Varenicline—nicotine dependence	0.00196	0.0122	CcSEcCtD
Imipramine—Breast disorder—Varenicline—nicotine dependence	0.00192	0.012	CcSEcCtD
Imipramine—KCND2—brain—nicotine dependence	0.00191	0.0285	CbGeAlD
Imipramine—CHRM2—cardiovascular system—nicotine dependence	0.00174	0.0259	CbGeAlD
Imipramine—Pollakiuria—Varenicline—nicotine dependence	0.00169	0.0106	CcSEcCtD
Imipramine—Erectile dysfunction—Varenicline—nicotine dependence	0.00169	0.0105	CcSEcCtD
Imipramine—Photosensitivity reaction—Varenicline—nicotine dependence	0.00167	0.0104	CcSEcCtD
Imipramine—Weight increased—Varenicline—nicotine dependence	0.00167	0.0104	CcSEcCtD
Imipramine—KCND3—brain—nicotine dependence	0.00167	0.0248	CbGeAlD
Imipramine—Infestation—Varenicline—nicotine dependence	0.00164	0.0102	CcSEcCtD
Imipramine—Infestation NOS—Varenicline—nicotine dependence	0.00164	0.0102	CcSEcCtD
Imipramine—Acute coronary syndrome—Varenicline—nicotine dependence	0.00161	0.0101	CcSEcCtD
Imipramine—Myocardial infarction—Varenicline—nicotine dependence	0.0016	0.01	CcSEcCtD
Imipramine—Stomatitis—Varenicline—nicotine dependence	0.00159	0.00995	CcSEcCtD
Imipramine—CHRM4—brain—nicotine dependence	0.00159	0.0237	CbGeAlD
Imipramine—CHRM1—cardiovascular system—nicotine dependence	0.00158	0.0235	CbGeAlD
Imipramine—Hepatobiliary disease—Varenicline—nicotine dependence	0.00155	0.00965	CcSEcCtD
Imipramine—Hallucination—Varenicline—nicotine dependence	0.00146	0.00911	CcSEcCtD
Imipramine—Hypoaesthesia—Varenicline—nicotine dependence	0.00146	0.00911	CcSEcCtD
Imipramine—Urinary tract disorder—Varenicline—nicotine dependence	0.00145	0.00905	CcSEcCtD
Imipramine—Urethral disorder—Varenicline—nicotine dependence	0.00144	0.00898	CcSEcCtD
Imipramine—HTR6—brain—nicotine dependence	0.00142	0.0212	CbGeAlD
Imipramine—HTR1A—cardiovascular system—nicotine dependence	0.00141	0.021	CbGeAlD
Imipramine—Eye disorder—Varenicline—nicotine dependence	0.00137	0.00856	CcSEcCtD
Imipramine—Tinnitus—Varenicline—nicotine dependence	0.00137	0.00854	CcSEcCtD
Imipramine—Cardiac disorder—Varenicline—nicotine dependence	0.00136	0.0085	CcSEcCtD
Imipramine—SLC6A3—midbrain—nicotine dependence	0.00135	0.0201	CbGeAlD
Imipramine—HTR7—cardiovascular system—nicotine dependence	0.00135	0.0201	CbGeAlD
Imipramine—Angiopathy—Varenicline—nicotine dependence	0.00133	0.00831	CcSEcCtD
Imipramine—Immune system disorder—Varenicline—nicotine dependence	0.00133	0.00827	CcSEcCtD
Imipramine—Mediastinal disorder—Varenicline—nicotine dependence	0.00132	0.00826	CcSEcCtD
Imipramine—Arrhythmia—Varenicline—nicotine dependence	0.00131	0.00818	CcSEcCtD
Imipramine—HTR2C—midbrain—nicotine dependence	0.00131	0.0195	CbGeAlD
Imipramine—ADRA1A—cardiovascular system—nicotine dependence	0.0013	0.0193	CbGeAlD
Imipramine—Mental disorder—Varenicline—nicotine dependence	0.00129	0.00803	CcSEcCtD
Imipramine—Malnutrition—Varenicline—nicotine dependence	0.00128	0.00797	CcSEcCtD
Imipramine—KCNH2—cardiovascular system—nicotine dependence	0.00126	0.0187	CbGeAlD
Imipramine—Dysgeusia—Varenicline—nicotine dependence	0.00125	0.00781	CcSEcCtD
Imipramine—CHRM5—brain—nicotine dependence	0.00124	0.0185	CbGeAlD
Imipramine—SLC6A4—midbrain—nicotine dependence	0.00124	0.0185	CbGeAlD
Imipramine—Vision blurred—Varenicline—nicotine dependence	0.0012	0.00752	CcSEcCtD
Imipramine—Tremor—Varenicline—nicotine dependence	0.0012	0.00747	CcSEcCtD
Imipramine—Ill-defined disorder—Varenicline—nicotine dependence	0.00119	0.0074	CcSEcCtD
Imipramine—Agitation—Varenicline—nicotine dependence	0.00117	0.00733	CcSEcCtD
Imipramine—Malaise—Varenicline—nicotine dependence	0.00115	0.00719	CcSEcCtD
Imipramine—Syncope—Varenicline—nicotine dependence	0.00115	0.00715	CcSEcCtD
Imipramine—ADRA1B—brain—nicotine dependence	0.00114	0.0169	CbGeAlD
Imipramine—Palpitations—Varenicline—nicotine dependence	0.00113	0.00705	CcSEcCtD
Imipramine—Loss of consciousness—Varenicline—nicotine dependence	0.00112	0.00701	CcSEcCtD
Imipramine—ADRA1D—brain—nicotine dependence	0.00111	0.0165	CbGeAlD
Imipramine—Convulsion—Varenicline—nicotine dependence	0.00111	0.00691	CcSEcCtD
Imipramine—Hypertension—Varenicline—nicotine dependence	0.0011	0.00688	CcSEcCtD
Imipramine—HTR1A—midbrain—nicotine dependence	0.0011	0.0164	CbGeAlD
Imipramine—Anxiety—Varenicline—nicotine dependence	0.00108	0.00677	CcSEcCtD
Imipramine—Unspecified disorder of skin and subcutaneous tissue—Varenicline—nicotine dependence	0.00108	0.00674	CcSEcCtD
Imipramine—Discomfort—Varenicline—nicotine dependence	0.00108	0.00671	CcSEcCtD
Imipramine—Dry mouth—Varenicline—nicotine dependence	0.00106	0.00664	CcSEcCtD
Imipramine—HTR7—midbrain—nicotine dependence	0.00105	0.0157	CbGeAlD
Imipramine—Oedema—Varenicline—nicotine dependence	0.00104	0.00651	CcSEcCtD
Imipramine—Infection—Varenicline—nicotine dependence	0.00104	0.00647	CcSEcCtD
Imipramine—CYP2B6—cardiovascular system—nicotine dependence	0.00103	0.0153	CbGeAlD
Imipramine—Shock—Varenicline—nicotine dependence	0.00103	0.0064	CcSEcCtD
Imipramine—Nervous system disorder—Varenicline—nicotine dependence	0.00102	0.00638	CcSEcCtD
Imipramine—Thrombocytopenia—Varenicline—nicotine dependence	0.00102	0.00637	CcSEcCtD
Imipramine—Tachycardia—Varenicline—nicotine dependence	0.00102	0.00635	CcSEcCtD
Imipramine—Skin disorder—Varenicline—nicotine dependence	0.00101	0.00632	CcSEcCtD
Imipramine—Hyperhidrosis—Varenicline—nicotine dependence	0.00101	0.00629	CcSEcCtD
Imipramine—DRD2—midbrain—nicotine dependence	0.000995	0.0148	CbGeAlD
Imipramine—Anorexia—Varenicline—nicotine dependence	0.000994	0.0062	CcSEcCtD
Imipramine—KCNH2—midbrain—nicotine dependence	0.00098	0.0146	CbGeAlD
Imipramine—CYP2E1—cardiovascular system—nicotine dependence	0.000967	0.0144	CbGeAlD
Imipramine—Insomnia—Varenicline—nicotine dependence	0.000944	0.00589	CcSEcCtD
Imipramine—Somnolence—Varenicline—nicotine dependence	0.000928	0.00579	CcSEcCtD
Imipramine—Dyspepsia—Varenicline—nicotine dependence	0.000918	0.00573	CcSEcCtD
Imipramine—Decreased appetite—Varenicline—nicotine dependence	0.000907	0.00566	CcSEcCtD
Imipramine—Gastrointestinal disorder—Varenicline—nicotine dependence	0.000901	0.00562	CcSEcCtD
Imipramine—Fatigue—Varenicline—nicotine dependence	0.000899	0.00561	CcSEcCtD
Imipramine—Constipation—Varenicline—nicotine dependence	0.000892	0.00557	CcSEcCtD
Imipramine—SLC22A4—brain—nicotine dependence	0.00088	0.0131	CbGeAlD
Imipramine—Feeling abnormal—Varenicline—nicotine dependence	0.00086	0.00536	CcSEcCtD
Imipramine—Gastrointestinal pain—Varenicline—nicotine dependence	0.000853	0.00532	CcSEcCtD
Imipramine—CHRM2—brain—nicotine dependence	0.000853	0.0127	CbGeAlD
Imipramine—SLC6A3—brain—nicotine dependence	0.00085	0.0127	CbGeAlD
Imipramine—HTR2A—cardiovascular system—nicotine dependence	0.00084	0.0125	CbGeAlD
Imipramine—SLC22A1—brain—nicotine dependence	0.000838	0.0125	CbGeAlD
Imipramine—Urticaria—Varenicline—nicotine dependence	0.000829	0.00517	CcSEcCtD
Imipramine—Body temperature increased—Varenicline—nicotine dependence	0.000825	0.00514	CcSEcCtD
Imipramine—Abdominal pain—Varenicline—nicotine dependence	0.000825	0.00514	CcSEcCtD
Imipramine—HTR2C—brain—nicotine dependence	0.000822	0.0122	CbGeAlD
Imipramine—SLC22A3—brain—nicotine dependence	0.000801	0.0119	CbGeAlD
Imipramine—SLC6A4—brain—nicotine dependence	0.000779	0.0116	CbGeAlD
Imipramine—CHRM1—brain—nicotine dependence	0.000776	0.0116	CbGeAlD
Imipramine—Asthenia—Varenicline—nicotine dependence	0.000749	0.00467	CcSEcCtD
Imipramine—Pruritus—Varenicline—nicotine dependence	0.000738	0.0046	CcSEcCtD
Imipramine—Diarrhoea—Varenicline—nicotine dependence	0.000714	0.00445	CcSEcCtD
Imipramine—CHRM3—brain—nicotine dependence	0.000695	0.0103	CbGeAlD
Imipramine—HTR1A—brain—nicotine dependence	0.000692	0.0103	CbGeAlD
Imipramine—Dizziness—Varenicline—nicotine dependence	0.00069	0.0043	CcSEcCtD
Imipramine—SLC6A2—brain—nicotine dependence	0.000686	0.0102	CbGeAlD
Imipramine—Vomiting—Varenicline—nicotine dependence	0.000663	0.00414	CcSEcCtD
Imipramine—HTR7—brain—nicotine dependence	0.000661	0.00984	CbGeAlD
Imipramine—Rash—Varenicline—nicotine dependence	0.000658	0.0041	CcSEcCtD
Imipramine—Dermatitis—Varenicline—nicotine dependence	0.000657	0.0041	CcSEcCtD
Imipramine—HTR2A—midbrain—nicotine dependence	0.000656	0.00976	CbGeAlD
Imipramine—Headache—Varenicline—nicotine dependence	0.000654	0.00408	CcSEcCtD
Imipramine—ADRA1A—brain—nicotine dependence	0.000638	0.00949	CbGeAlD
Imipramine—DRD2—brain—nicotine dependence	0.000625	0.0093	CbGeAlD
Imipramine—Nausea—Varenicline—nicotine dependence	0.00062	0.00387	CcSEcCtD
Imipramine—KCNH2—brain—nicotine dependence	0.000616	0.00917	CbGeAlD
Imipramine—Maprotiline—DRD2—nicotine dependence	0.000585	0.0906	CrCbGaD
Imipramine—ABCB1—cardiovascular system—nicotine dependence	0.000551	0.00819	CbGeAlD
Imipramine—Triflupromazine—DRD2—nicotine dependence	0.000511	0.0792	CrCbGaD
Imipramine—CYP2B6—brain—nicotine dependence	0.000505	0.00752	CbGeAlD
Imipramine—HRH1—brain—nicotine dependence	0.000494	0.00735	CbGeAlD
Imipramine—CYP2E1—brain—nicotine dependence	0.000474	0.00706	CbGeAlD
Imipramine—Acepromazine—DRD2—nicotine dependence	0.000473	0.0732	CrCbGaD
Imipramine—Thioproperazine—DRD2—nicotine dependence	0.000462	0.0716	CrCbGaD
Imipramine—Pipotiazine—DRD2—nicotine dependence	0.000455	0.0704	CrCbGaD
Imipramine—Amitriptyline—OPRM1—nicotine dependence	0.000445	0.0689	CrCbGaD
Imipramine—Prochlorperazine—DRD2—nicotine dependence	0.000435	0.0673	CrCbGaD
Imipramine—ABCB1—midbrain—nicotine dependence	0.00043	0.0064	CbGeAlD
Imipramine—HTR2A—brain—nicotine dependence	0.000412	0.00614	CbGeAlD
Imipramine—Mianserin—DRD2—nicotine dependence	0.000393	0.0609	CrCbGaD
Imipramine—CYP2D6—brain—nicotine dependence	0.000376	0.00559	CbGeAlD
Imipramine—Nortriptyline—DRD2—nicotine dependence	0.000351	0.0544	CrCbGaD
Imipramine—Trimipramine—DRD2—nicotine dependence	0.000331	0.0512	CrCbGaD
Imipramine—Methotrimeprazine—DRD2—nicotine dependence	0.000323	0.0501	CrCbGaD
Imipramine—Promethazine—DRD2—nicotine dependence	0.000318	0.0493	CrCbGaD
Imipramine—Doxepin—DRD2—nicotine dependence	0.000315	0.0488	CrCbGaD
Imipramine—Desipramine—DRD2—nicotine dependence	0.000289	0.0448	CrCbGaD
Imipramine—Promazine—DRD2—nicotine dependence	0.00028	0.0434	CrCbGaD
Imipramine—ABCB1—brain—nicotine dependence	0.00027	0.00402	CbGeAlD
Imipramine—Chlorpromazine—DRD2—nicotine dependence	0.000247	0.0382	CrCbGaD
Imipramine—Amitriptyline—DRD2—nicotine dependence	0.000244	0.0377	CrCbGaD
Imipramine—HTR2C—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000121	0.000808	CbGpPWpGaD
Imipramine—SLC22A1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.00012	0.000804	CbGpPWpGaD
Imipramine—ADRA1D—Signaling by GPCR—FGD1—nicotine dependence	0.00012	0.000803	CbGpPWpGaD
Imipramine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000119	0.000798	CbGpPWpGaD
Imipramine—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	0.000119	0.000795	CbGpPWpGaD
Imipramine—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000117	0.000784	CbGpPWpGaD
Imipramine—DRD2—Signaling by GPCR—TAS2R16—nicotine dependence	0.000117	0.000783	CbGpPWpGaD
Imipramine—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000116	0.000773	CbGpPWpGaD
Imipramine—HTR1A—GPCR downstream signaling—FGD1—nicotine dependence	0.000115	0.000771	CbGpPWpGaD
Imipramine—HTR2A—Signaling by GPCR—TAS2R16—nicotine dependence	0.000115	0.000771	CbGpPWpGaD
Imipramine—HRH1—Signaling by GPCR—TAS2R16—nicotine dependence	0.000115	0.000769	CbGpPWpGaD
Imipramine—HTR2C—GPCR downstream signaling—FGD1—nicotine dependence	0.000115	0.000767	CbGpPWpGaD
Imipramine—CHRM1—Signaling by GPCR—TAS2R16—nicotine dependence	0.000114	0.000766	CbGpPWpGaD
Imipramine—CHRM3—Signaling by GPCR—TAS2R16—nicotine dependence	0.000114	0.000764	CbGpPWpGaD
Imipramine—CHRM2—Signaling by GPCR—TAS2R16—nicotine dependence	0.000113	0.000757	CbGpPWpGaD
Imipramine—ADRA1A—Signaling by GPCR—TAS2R16—nicotine dependence	0.000113	0.000754	CbGpPWpGaD
Imipramine—CHRM2—G alpha (i) signalling events—DRD2—nicotine dependence	0.000111	0.000742	CbGpPWpGaD
Imipramine—ADRA1B—GPCR downstream signaling—FGD1—nicotine dependence	0.00011	0.000734	CbGpPWpGaD
Imipramine—HTR1A—GPCR ligand binding—OPRM1—nicotine dependence	0.000109	0.000733	CbGpPWpGaD
Imipramine—HTR2C—GPCR ligand binding—OPRM1—nicotine dependence	0.000109	0.000729	CbGpPWpGaD
Imipramine—HTR6—GPCR ligand binding—DRD2—nicotine dependence	0.000107	0.000716	CbGpPWpGaD
Imipramine—HTR7—GPCR ligand binding—DRD2—nicotine dependence	0.000107	0.000715	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—TAS2R16—nicotine dependence	0.000106	0.000712	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—TAS2R16—nicotine dependence	0.000106	0.000711	CbGpPWpGaD
Imipramine—HTR2A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000105	0.000701	CbGpPWpGaD
Imipramine—HRH1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000105	0.0007	CbGpPWpGaD
Imipramine—HTR1A—Signaling by GPCR—FGD1—nicotine dependence	0.000105	0.0007	CbGpPWpGaD
Imipramine—ADRA1B—GPCR ligand binding—OPRM1—nicotine dependence	0.000104	0.000698	CbGpPWpGaD
Imipramine—CHRM1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000104	0.000698	CbGpPWpGaD
Imipramine—HTR2C—Signaling by GPCR—FGD1—nicotine dependence	0.000104	0.000696	CbGpPWpGaD
Imipramine—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000104	0.000696	CbGpPWpGaD
Imipramine—CHRM3—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000104	0.000695	CbGpPWpGaD
Imipramine—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000103	0.000692	CbGpPWpGaD
Imipramine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000103	0.000689	CbGpPWpGaD
Imipramine—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000103	0.000687	CbGpPWpGaD
Imipramine—DRD2—GPCR downstream signaling—FGD1—nicotine dependence	0.000101	0.000677	CbGpPWpGaD
Imipramine—CHRM4—GPCR ligand binding—DRD2—nicotine dependence	0.000101	0.000675	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—TAS2R16—nicotine dependence	0.0001	0.000671	CbGpPWpGaD
Imipramine—ADRA1B—Signaling by GPCR—FGD1—nicotine dependence	9.96e-05	0.000667	CbGpPWpGaD
Imipramine—HTR2A—GPCR downstream signaling—FGD1—nicotine dependence	9.95e-05	0.000666	CbGpPWpGaD
Imipramine—HRH1—GPCR downstream signaling—FGD1—nicotine dependence	9.93e-05	0.000664	CbGpPWpGaD
Imipramine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	9.9e-05	0.000662	CbGpPWpGaD
Imipramine—CHRM1—GPCR downstream signaling—FGD1—nicotine dependence	9.89e-05	0.000662	CbGpPWpGaD
Imipramine—CHRM3—GPCR downstream signaling—FGD1—nicotine dependence	9.86e-05	0.00066	CbGpPWpGaD
Imipramine—CHRM2—GPCR downstream signaling—FGD1—nicotine dependence	9.77e-05	0.000654	CbGpPWpGaD
Imipramine—ADRA1A—GPCR downstream signaling—FGD1—nicotine dependence	9.74e-05	0.000652	CbGpPWpGaD
Imipramine—CHRM5—GPCR ligand binding—DRD2—nicotine dependence	9.66e-05	0.000646	CbGpPWpGaD
Imipramine—SLC22A3—Metabolism—CYP2A7—nicotine dependence	9.62e-05	0.000644	CbGpPWpGaD
Imipramine—DRD2—GPCR ligand binding—OPRM1—nicotine dependence	9.61e-05	0.000643	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—TAS2R16—nicotine dependence	9.61e-05	0.000643	CbGpPWpGaD
Imipramine—HTR2A—GPCR ligand binding—OPRM1—nicotine dependence	9.46e-05	0.000633	CbGpPWpGaD
Imipramine—HRH1—GPCR ligand binding—OPRM1—nicotine dependence	9.44e-05	0.000632	CbGpPWpGaD
Imipramine—CHRM1—GPCR ligand binding—OPRM1—nicotine dependence	9.41e-05	0.00063	CbGpPWpGaD
Imipramine—CHRM3—GPCR ligand binding—OPRM1—nicotine dependence	9.38e-05	0.000628	CbGpPWpGaD
Imipramine—CHRM2—GPCR ligand binding—OPRM1—nicotine dependence	9.28e-05	0.000621	CbGpPWpGaD
Imipramine—ADRA1A—GPCR ligand binding—OPRM1—nicotine dependence	9.26e-05	0.00062	CbGpPWpGaD
Imipramine—DRD2—Signaling by GPCR—FGD1—nicotine dependence	9.18e-05	0.000614	CbGpPWpGaD
Imipramine—CYP2C18—Metabolism—CYP2A7—nicotine dependence	9.09e-05	0.000609	CbGpPWpGaD
Imipramine—ADRA1D—GPCR ligand binding—DRD2—nicotine dependence	9.08e-05	0.000608	CbGpPWpGaD
Imipramine—HTR2A—Signaling by GPCR—FGD1—nicotine dependence	9.03e-05	0.000605	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—TAS2R16—nicotine dependence	9.03e-05	0.000605	CbGpPWpGaD
Imipramine—HRH1—Signaling by GPCR—FGD1—nicotine dependence	9.01e-05	0.000603	CbGpPWpGaD
Imipramine—CHRM1—Signaling by GPCR—FGD1—nicotine dependence	8.98e-05	0.000601	CbGpPWpGaD
Imipramine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	8.98e-05	0.000601	CbGpPWpGaD
Imipramine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	8.96e-05	0.0006	CbGpPWpGaD
Imipramine—CHRM3—Signaling by GPCR—FGD1—nicotine dependence	8.96e-05	0.000599	CbGpPWpGaD
Imipramine—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	8.93e-05	0.000598	CbGpPWpGaD
Imipramine—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	8.9e-05	0.000596	CbGpPWpGaD
Imipramine—CHRM2—Signaling by GPCR—FGD1—nicotine dependence	8.87e-05	0.000594	CbGpPWpGaD
Imipramine—ADRA1A—Signaling by GPCR—FGD1—nicotine dependence	8.84e-05	0.000592	CbGpPWpGaD
Imipramine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	8.81e-05	0.00059	CbGpPWpGaD
Imipramine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	8.79e-05	0.000588	CbGpPWpGaD
Imipramine—HTR6—GPCR downstream signaling—OPRM1—nicotine dependence	8.36e-05	0.000559	CbGpPWpGaD
Imipramine—HTR7—GPCR downstream signaling—OPRM1—nicotine dependence	8.35e-05	0.000559	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—FGD1—nicotine dependence	8.34e-05	0.000559	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—FGD1—nicotine dependence	8.34e-05	0.000558	CbGpPWpGaD
Imipramine—HTR1A—GPCR ligand binding—DRD2—nicotine dependence	7.91e-05	0.00053	CbGpPWpGaD
Imipramine—CHRM4—GPCR downstream signaling—OPRM1—nicotine dependence	7.88e-05	0.000528	CbGpPWpGaD
Imipramine—HTR2C—GPCR ligand binding—DRD2—nicotine dependence	7.87e-05	0.000527	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—TAS2R16—nicotine dependence	7.87e-05	0.000527	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—FGD1—nicotine dependence	7.87e-05	0.000527	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—TAS2R16—nicotine dependence	7.83e-05	0.000524	CbGpPWpGaD
Imipramine—HTR6—Signaling by GPCR—OPRM1—nicotine dependence	7.59e-05	0.000508	CbGpPWpGaD
Imipramine—HTR7—Signaling by GPCR—OPRM1—nicotine dependence	7.58e-05	0.000507	CbGpPWpGaD
Imipramine—CHRM5—GPCR downstream signaling—OPRM1—nicotine dependence	7.55e-05	0.000505	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—FGD1—nicotine dependence	7.54e-05	0.000505	CbGpPWpGaD
Imipramine—ADRA1B—GPCR ligand binding—DRD2—nicotine dependence	7.54e-05	0.000504	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—TAS2R16—nicotine dependence	7.5e-05	0.000502	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—AKR1B10—nicotine dependence	7.37e-05	0.000493	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—AKR1B10—nicotine dependence	7.36e-05	0.000493	CbGpPWpGaD
Imipramine—CHRM4—Signaling by GPCR—OPRM1—nicotine dependence	7.16e-05	0.000479	CbGpPWpGaD
Imipramine—ADRA1D—GPCR downstream signaling—OPRM1—nicotine dependence	7.1e-05	0.000475	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—FGD1—nicotine dependence	7.09e-05	0.000474	CbGpPWpGaD
Imipramine—ABCB1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	7.04e-05	0.000471	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—AKR1B10—nicotine dependence	6.95e-05	0.000465	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—TAS2R16—nicotine dependence	6.91e-05	0.000463	CbGpPWpGaD
Imipramine—CHRM5—Signaling by GPCR—OPRM1—nicotine dependence	6.86e-05	0.000459	CbGpPWpGaD
Imipramine—HTR2A—GPCR ligand binding—DRD2—nicotine dependence	6.84e-05	0.000458	CbGpPWpGaD
Imipramine—HRH1—GPCR ligand binding—DRD2—nicotine dependence	6.82e-05	0.000457	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—TAS2R16—nicotine dependence	6.8e-05	0.000455	CbGpPWpGaD
Imipramine—CHRM1—GPCR ligand binding—DRD2—nicotine dependence	6.8e-05	0.000455	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—TAS2R16—nicotine dependence	6.79e-05	0.000454	CbGpPWpGaD
Imipramine—CHRM3—GPCR ligand binding—DRD2—nicotine dependence	6.78e-05	0.000454	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—TAS2R16—nicotine dependence	6.76e-05	0.000453	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—TAS2R16—nicotine dependence	6.74e-05	0.000451	CbGpPWpGaD
Imipramine—CHRM2—GPCR ligand binding—DRD2—nicotine dependence	6.71e-05	0.000449	CbGpPWpGaD
Imipramine—ADRA1A—GPCR ligand binding—DRD2—nicotine dependence	6.69e-05	0.000448	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—TAS2R16—nicotine dependence	6.68e-05	0.000447	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—AKR1B10—nicotine dependence	6.66e-05	0.000446	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—TAS2R16—nicotine dependence	6.66e-05	0.000446	CbGpPWpGaD
Imipramine—ADRA1D—Signaling by GPCR—OPRM1—nicotine dependence	6.45e-05	0.000431	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—AKR1B10—nicotine dependence	6.26e-05	0.000419	CbGpPWpGaD
Imipramine—HTR1A—GPCR downstream signaling—OPRM1—nicotine dependence	6.19e-05	0.000414	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—FGD1—nicotine dependence	6.18e-05	0.000413	CbGpPWpGaD
Imipramine—HTR2C—GPCR downstream signaling—OPRM1—nicotine dependence	6.15e-05	0.000412	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—FGD1—nicotine dependence	6.14e-05	0.000411	CbGpPWpGaD
Imipramine—CYP3A7—Metabolism—CYP2A7—nicotine dependence	6.04e-05	0.000405	CbGpPWpGaD
Imipramine—HTR6—GPCR downstream signaling—DRD2—nicotine dependence	6.04e-05	0.000404	CbGpPWpGaD
Imipramine—HTR7—GPCR downstream signaling—DRD2—nicotine dependence	6.03e-05	0.000404	CbGpPWpGaD
Imipramine—SLC22A2—Metabolism—CYP2A7—nicotine dependence	6.03e-05	0.000404	CbGpPWpGaD
Imipramine—ADRA1B—GPCR downstream signaling—OPRM1—nicotine dependence	5.89e-05	0.000394	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—FGD1—nicotine dependence	5.88e-05	0.000394	CbGpPWpGaD
Imipramine—CHRM4—GPCR downstream signaling—DRD2—nicotine dependence	5.7e-05	0.000381	CbGpPWpGaD
Imipramine—SLC22A1—Metabolism—CYP2A7—nicotine dependence	5.62e-05	0.000376	CbGpPWpGaD
Imipramine—HTR1A—Signaling by GPCR—OPRM1—nicotine dependence	5.62e-05	0.000376	CbGpPWpGaD
Imipramine—HTR2C—Signaling by GPCR—OPRM1—nicotine dependence	5.59e-05	0.000374	CbGpPWpGaD
Imipramine—HTR6—Signaling by GPCR—DRD2—nicotine dependence	5.49e-05	0.000367	CbGpPWpGaD
Imipramine—HTR7—Signaling by GPCR—DRD2—nicotine dependence	5.48e-05	0.000367	CbGpPWpGaD
Imipramine—CHRM5—GPCR downstream signaling—DRD2—nicotine dependence	5.46e-05	0.000365	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—AKR1B10—nicotine dependence	5.46e-05	0.000365	CbGpPWpGaD
Imipramine—DRD2—GPCR downstream signaling—OPRM1—nicotine dependence	5.43e-05	0.000364	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—AKR1B10—nicotine dependence	5.43e-05	0.000363	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—FGD1—nicotine dependence	5.42e-05	0.000363	CbGpPWpGaD
Imipramine—ADRA1B—Signaling by GPCR—OPRM1—nicotine dependence	5.35e-05	0.000358	CbGpPWpGaD
Imipramine—HTR2A—GPCR downstream signaling—OPRM1—nicotine dependence	5.34e-05	0.000358	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—FGD1—nicotine dependence	5.34e-05	0.000357	CbGpPWpGaD
Imipramine—HRH1—GPCR downstream signaling—OPRM1—nicotine dependence	5.33e-05	0.000357	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—FGD1—nicotine dependence	5.32e-05	0.000356	CbGpPWpGaD
Imipramine—CHRM1—GPCR downstream signaling—OPRM1—nicotine dependence	5.32e-05	0.000356	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—FGD1—nicotine dependence	5.31e-05	0.000355	CbGpPWpGaD
Imipramine—CHRM3—GPCR downstream signaling—OPRM1—nicotine dependence	5.3e-05	0.000355	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—FGD1—nicotine dependence	5.29e-05	0.000354	CbGpPWpGaD
Imipramine—CHRM2—GPCR downstream signaling—OPRM1—nicotine dependence	5.25e-05	0.000351	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—FGD1—nicotine dependence	5.24e-05	0.000351	CbGpPWpGaD
Imipramine—ADRA1A—GPCR downstream signaling—OPRM1—nicotine dependence	5.23e-05	0.00035	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—FGD1—nicotine dependence	5.22e-05	0.00035	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—AKR1B10—nicotine dependence	5.2e-05	0.000348	CbGpPWpGaD
Imipramine—CHRM3—Metabolism—CYP2A7—nicotine dependence	5.2e-05	0.000348	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—WASF2—nicotine dependence	5.19e-05	0.000348	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—WASF2—nicotine dependence	5.19e-05	0.000347	CbGpPWpGaD
Imipramine—CHRM4—Signaling by GPCR—DRD2—nicotine dependence	5.18e-05	0.000346	CbGpPWpGaD
Imipramine—ADRA1D—GPCR downstream signaling—DRD2—nicotine dependence	5.13e-05	0.000343	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—WASF1—nicotine dependence	4.98e-05	0.000333	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—WASF1—nicotine dependence	4.97e-05	0.000333	CbGpPWpGaD
Imipramine—CHRM5—Signaling by GPCR—DRD2—nicotine dependence	4.96e-05	0.000332	CbGpPWpGaD
Imipramine—DRD2—Signaling by GPCR—OPRM1—nicotine dependence	4.93e-05	0.00033	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—WASF2—nicotine dependence	4.9e-05	0.000328	CbGpPWpGaD
Imipramine—HTR2A—Signaling by GPCR—OPRM1—nicotine dependence	4.85e-05	0.000325	CbGpPWpGaD
Imipramine—HRH1—Signaling by GPCR—OPRM1—nicotine dependence	4.84e-05	0.000324	CbGpPWpGaD
Imipramine—CHRM1—Signaling by GPCR—OPRM1—nicotine dependence	4.83e-05	0.000323	CbGpPWpGaD
Imipramine—CHRM3—Signaling by GPCR—OPRM1—nicotine dependence	4.81e-05	0.000322	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—AKR1B10—nicotine dependence	4.79e-05	0.000321	CbGpPWpGaD
Imipramine—CHRM2—Signaling by GPCR—OPRM1—nicotine dependence	4.76e-05	0.000319	CbGpPWpGaD
Imipramine—ADRA1A—Signaling by GPCR—OPRM1—nicotine dependence	4.75e-05	0.000318	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—AKR1B10—nicotine dependence	4.71e-05	0.000315	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—AKR1B10—nicotine dependence	4.7e-05	0.000315	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—WASF1—nicotine dependence	4.7e-05	0.000314	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—WASF2—nicotine dependence	4.69e-05	0.000314	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—AKR1B10—nicotine dependence	4.69e-05	0.000314	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—AKR1B10—nicotine dependence	4.67e-05	0.000313	CbGpPWpGaD
Imipramine—ADRA1D—Signaling by GPCR—DRD2—nicotine dependence	4.66e-05	0.000312	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—AKR1B10—nicotine dependence	4.63e-05	0.00031	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—AKR1B10—nicotine dependence	4.62e-05	0.000309	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—WASF1—nicotine dependence	4.5e-05	0.000301	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—OPRM1—nicotine dependence	4.48e-05	0.0003	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—OPRM1—nicotine dependence	4.48e-05	0.0003	CbGpPWpGaD
Imipramine—HTR1A—GPCR downstream signaling—DRD2—nicotine dependence	4.47e-05	0.000299	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—CYP2A7—nicotine dependence	4.47e-05	0.000299	CbGpPWpGaD
Imipramine—HTR2C—GPCR downstream signaling—DRD2—nicotine dependence	4.45e-05	0.000298	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—WASF2—nicotine dependence	4.41e-05	0.000295	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—CYP2A7—nicotine dependence	4.38e-05	0.000293	CbGpPWpGaD
Imipramine—ADRA1B—GPCR downstream signaling—DRD2—nicotine dependence	4.26e-05	0.000285	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—OPRM1—nicotine dependence	4.23e-05	0.000283	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—WASF1—nicotine dependence	4.23e-05	0.000283	CbGpPWpGaD
Imipramine—HTR1A—Signaling by GPCR—DRD2—nicotine dependence	4.06e-05	0.000272	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—OPRM1—nicotine dependence	4.05e-05	0.000271	CbGpPWpGaD
Imipramine—HTR2C—Signaling by GPCR—DRD2—nicotine dependence	4.04e-05	0.00027	CbGpPWpGaD
Imipramine—ADRA1B—Signaling by GPCR—DRD2—nicotine dependence	3.87e-05	0.000259	CbGpPWpGaD
Imipramine—HTR2A—GPCR downstream signaling—DRD2—nicotine dependence	3.86e-05	0.000259	CbGpPWpGaD
Imipramine—HRH1—GPCR downstream signaling—DRD2—nicotine dependence	3.86e-05	0.000258	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—WASF2—nicotine dependence	3.84e-05	0.000257	CbGpPWpGaD
Imipramine—CHRM1—GPCR downstream signaling—DRD2—nicotine dependence	3.84e-05	0.000257	CbGpPWpGaD
Imipramine—CHRM3—GPCR downstream signaling—DRD2—nicotine dependence	3.83e-05	0.000256	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—WASF2—nicotine dependence	3.82e-05	0.000256	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—OPRM1—nicotine dependence	3.81e-05	0.000255	CbGpPWpGaD
Imipramine—CHRM2—GPCR downstream signaling—DRD2—nicotine dependence	3.79e-05	0.000254	CbGpPWpGaD
Imipramine—ADRA1A—GPCR downstream signaling—DRD2—nicotine dependence	3.78e-05	0.000253	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—WASF1—nicotine dependence	3.69e-05	0.000247	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—WASF1—nicotine dependence	3.67e-05	0.000245	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—WASF2—nicotine dependence	3.66e-05	0.000245	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—WASF1—nicotine dependence	3.51e-05	0.000235	CbGpPWpGaD
Imipramine—HTR2A—Signaling by GPCR—DRD2—nicotine dependence	3.51e-05	0.000235	CbGpPWpGaD
Imipramine—HRH1—Signaling by GPCR—DRD2—nicotine dependence	3.5e-05	0.000234	CbGpPWpGaD
Imipramine—CHRM1—Signaling by GPCR—DRD2—nicotine dependence	3.49e-05	0.000234	CbGpPWpGaD
Imipramine—CHRM3—Signaling by GPCR—DRD2—nicotine dependence	3.48e-05	0.000233	CbGpPWpGaD
Imipramine—CHRM2—Signaling by GPCR—DRD2—nicotine dependence	3.44e-05	0.000231	CbGpPWpGaD
Imipramine—ADRA1A—Signaling by GPCR—DRD2—nicotine dependence	3.44e-05	0.00023	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—CYP2A7—nicotine dependence	3.38e-05	0.000226	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—WASF2—nicotine dependence	3.38e-05	0.000226	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—WASF2—nicotine dependence	3.32e-05	0.000222	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—OPRM1—nicotine dependence	3.32e-05	0.000222	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—WASF2—nicotine dependence	3.31e-05	0.000222	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—WASF2—nicotine dependence	3.3e-05	0.000221	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—OPRM1—nicotine dependence	3.3e-05	0.000221	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—CYP2A7—nicotine dependence	3.3e-05	0.000221	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—WASF2—nicotine dependence	3.29e-05	0.00022	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—WASF2—nicotine dependence	3.26e-05	0.000218	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—WASF2—nicotine dependence	3.25e-05	0.000218	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—DRD2—nicotine dependence	3.24e-05	0.000217	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—DRD2—nicotine dependence	3.24e-05	0.000217	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—WASF1—nicotine dependence	3.24e-05	0.000217	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—WASF1—nicotine dependence	3.18e-05	0.000213	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—WASF1—nicotine dependence	3.18e-05	0.000213	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—WASF1—nicotine dependence	3.17e-05	0.000212	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—OPRM1—nicotine dependence	3.16e-05	0.000212	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—WASF1—nicotine dependence	3.16e-05	0.000211	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—WASF1—nicotine dependence	3.13e-05	0.000209	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—WASF1—nicotine dependence	3.12e-05	0.000209	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—CYP2A7—nicotine dependence	3.11e-05	0.000208	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—DRD2—nicotine dependence	3.06e-05	0.000205	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—DRD2—nicotine dependence	2.93e-05	0.000196	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—OPRM1—nicotine dependence	2.91e-05	0.000195	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—OPRM1—nicotine dependence	2.87e-05	0.000192	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—OPRM1—nicotine dependence	2.86e-05	0.000191	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—OPRM1—nicotine dependence	2.85e-05	0.000191	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—OPRM1—nicotine dependence	2.84e-05	0.00019	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—OPRM1—nicotine dependence	2.81e-05	0.000188	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—OPRM1—nicotine dependence	2.81e-05	0.000188	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—DRD2—nicotine dependence	2.75e-05	0.000184	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—CYP2A7—nicotine dependence	2.63e-05	0.000176	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—DRD2—nicotine dependence	2.4e-05	0.000161	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—DRD2—nicotine dependence	2.39e-05	0.00016	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—DRD2—nicotine dependence	2.28e-05	0.000153	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—DRD2—nicotine dependence	2.07e-05	0.000139	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—DRD2—nicotine dependence	2.07e-05	0.000138	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—DRD2—nicotine dependence	2.06e-05	0.000138	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—DRD2—nicotine dependence	2.05e-05	0.000138	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—DRD2—nicotine dependence	2.03e-05	0.000136	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—CYP2A7—nicotine dependence	2.03e-05	0.000136	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—DRD2—nicotine dependence	2.03e-05	0.000136	CbGpPWpGaD
